Dendreon (DNDN) shares -10.3% after it confirms that the SEC has opened an investigation, which could be connected to lawsuits accusing the company of misleading investors over prostate-cancer treatment Provenge
I have to stop saying..."How stupid can you be?"
Some people are taking it as a Challenge...**Grins**